| Date Filed | Type | Description |
| 08/18/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 694,124 shares
@ $0
Acquired 2,610 shares
@ $0
Acquired 21,248 shares
@ $0 |
|
| 05/30/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 9,288 shares
@ $0
Granted 33,175 options to buy
@ $3.23, valued at
$107.2k
|
|
| 05/15/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 215,576 shares
@ $0
Acquired 41,219 shares
@ $0 |
|
| 03/17/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 215,575 shares
@ $0
Acquired 52,194 shares
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 316,694 shares
@ $0
Acquired 107,236 shares
@ $0 |
|
| 07/01/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 7,000 options to buy
@ $12.89, valued at
$90.2k
Granted 2,000 restricted stock units
@ $0 |
|
| 06/09/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 375,000 shares
@ $0
Acquired 126,979 shares
@ $0 |
|
| 06/08/2022 |
4/A
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Acquired 126,979 shares
@ $0 |
|
| 06/08/2022 |
4/A
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Acquired 126,979 shares
@ $0 |
|
| 06/03/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 10,349 shares
@ $0 |
|
| 05/31/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 4,285 shares
@ $0
Granted 15,616 options to buy
@ $7, valued at
$109.3k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 375,000 shares
@ $0 |
|
| 01/07/2022 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Acquired 6,438 shares
@ $0
Acquired 401 shares
@ $0 |
|
| 12/23/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Acquired 6,438 shares
@ $0
Acquired 400 shares
@ $0 |
|
| 11/16/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 250,000 shares
@ $0
Acquired 4,348 shares
@ $0 |
|
| 10/20/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Sold 303,614 shares
@ $14.6327, valued at
$4.4M
Sold 242,943 shares
@ $15.0939, valued at
$3.7M
Sold 1,912 shares
@ $14.6327, valued at
$28k
Sold 1,531 shares
@ $15.0939, valued at
$23.1k
|
|
| 08/05/2021 |
4
| LINK WILLIAM J PHD (10% Owner) has filed a Form 4 on RxSight, Inc.|
Txns:
| Converted 2,016,778 shares
@ $0
Bought 31,250 shares
@ $16, valued at
$500k
Converted 2,016,778 preferred shares
@ $0 |
|
| 08/02/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 5,859 shares
@ $0 |
|
| 07/29/2021 |
3
| LINK WILLIAM J PHD (10% Owner) has filed a Form 3 on RxSight, Inc. |
| 06/17/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $35.26, valued at
$352.6k
|
|
| 06/09/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 3,466 shares
@ $0
Granted 5,199 options to buy
@ $17.74, valued at
$92.2k
|
|
| 06/07/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,382 shares
@ $0 |
|
| 05/20/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 20,847 options to buy
@ $7.49, valued at
$156.1k
|
|
| 05/14/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Acquired 10,302 shares
@ $0
Acquired 642 shares
@ $0 |
|
| 03/30/2021 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Acquired 10,302 shares
@ $0
Acquired 631 shares
@ $0 |
|
| 12/14/2020 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Disposed of 955,392 shares
@ $0
Acquired 27,942 shares
@ $0 |
|
| 12/10/2020 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 80,157 shares
@ $0 |
|
| 12/03/2020 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Sold 49,400 shares
@ $67.9573, valued at
$3.4M
Sold 600 shares
@ $68.7197, valued at
$41.2k
Exercised 10,000 options to buy
@ $7.275, valued at
$72.8k
Exercised 25,000 options to buy
@ $32, valued at
$800k
Exercised 15,000 options to buy
@ $24.69, valued at
$370.4k
|
|
| 10/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|